These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19563346)

  • 21. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Felbamate levels in patients with epilepsy.
    Harden CL; Trifiletti R; Kutt H
    Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of felbamate in pediatric and adult beagle dogs.
    Adusumalli VE; Gilchrist JR; Wichmann JK; Kucharczyk N; Sofia RD
    Epilepsia; 1992; 33(5):955-60. PubMed ID: 1396441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):133-42. PubMed ID: 15695057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.
    Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P
    Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term use of felbamate in children with severe refractory epilepsy.
    Cilio MR; Kartashov AI; Vigevano F
    Epilepsy Res; 2001 Nov; 47(1-2):1-7. PubMed ID: 11673015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of felbamate in children with refractory epilepsy.
    Heyman E; Levin N; Lahat E; Epstein O; Gandelman-Marton R
    Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felbamate in experimental model of status epilepticus.
    Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?
    Cuadrado A; Amat G; Armijo JA
    Pharmacol Res; 2003 Aug; 48(2):183-92. PubMed ID: 12798671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Felbamate-induced headache.
    Ettinger AB; Jandorf L; Berdia A; Andriola MR; Krupp LB; Weisbrot DM
    Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.
    Banfield CR; Zhu GR; Jen JF; Jensen PK; Schumaker RC; Perhach JL; Affrime MB; Glue P
    Ther Drug Monit; 1996 Feb; 18(1):19-29. PubMed ID: 8848816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of felbamate in the treatment of intractable pediatric epilepsy.
    Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA
    Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of case reports of aplastic anemia among patients treated with felbamate.
    Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S
    Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Felbamate.
    Graves NM
    Ann Pharmacother; 1993 Sep; 27(9):1073-81. PubMed ID: 8219443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Aug; 45(8):895-907. PubMed ID: 15270754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.